Member List.

  • Abcuro

    Abcuro is a clinical stage biotechnology company developing potentially first-in-class immunotherapies designed to benefit people living with debilitating and progressive rare autoimmune diseases and for other indications where certain cytotoxic T cells are pathogenic.

  • Avstera

    Avstera Therapeutics is a biotech company dedicated to addressing large disease burdens and unmet patient needs by leveraging cutting-edge immunological cell insights to develop novel therapeutics. Their focus includes immunological challenges in cancer, obesity, and cardiovascular indications.

  • Biomedica

    Biomedica is a pharmaceutical company specializing in the commercialization of rare disease, innovative, and breakthrough therapies in underserved and emerging markets.

  • BrainTree Labs/Sebela

    Sebela Pharmaceuticals is a U.S. pharmaceutical company with a market-leading position in Gastroenterology and a focus on innovation in Women's Health.

  • CG Life

    CG Life offers expanded capabilities, deeper intelligence, and new strategies to help promising therapies reach the people who need them most.

  • CoCrystal

    We are a clinical-stage biotechnology company developing novel therapeutics to meet the growing global need for effective, safe antiviral treatments. We employ a unique structure-based drug discovery technology platform and Nobel Prize-winning expertise to create viable antiviral drugs. Our antivirals target the replication process and are designed to be safe, broad-spectrum, resistant and convenient to administer.

  • Cogent

    Cogent Biosciences is a biotechnology company developing real solutions to treat genetically driven diseases. With a focus on the design of rational precision therapies, we are leveraging validated biology to address the true underlying drivers of disease and provide real hope for patients.

  • Coherus Oncology

    Coherus Oncology is focused on developing and commercializing a diversified portfolio of next-generation immuno-oncology therapies that potentially extend patient survival across tumor types.

  • Danaher Corporation

    Danaher is a leading global life sciences and diagnostics innovator, helping to solve many of the world’s most important health challenges. Ultimately improving quality of life for billions of people today, while setting the foundation for a healthier, more sustainable tomorrow.

  • Endeavor BioMedicines

    Endeavor BioMedicines is a clinical-stage biotechnology company focused on developing medicines for the treatment of fibrotic diseases with high unmet need. By unlocking the therapeutic potential of the Hedgehog (Hh) signaling pathway, Endeavor is advancing a new approach to addressing fibrosis across organ systems.

  • Gamida Cell

    At Gamida Cell, we are cell therapy pioneers working to turn cells into powerful therapeutics. We work with a sense of urgency and deeply held responsibility to address the clear need for new treatment options. And we do all that we can to ensure access to our therapies for patients who can benefit from them.

  • Humphrey Health

    Humphrey Health’s mission is to empower individuals to take control of their health through homeopathy. Whether you’re new to homeopathy or looking to deepen your understanding, my goal is to guide you on your journey to wellness using safe, natural remedies.

  • INmune Bio

    INmune Bio Inc. is a clinical stage biotechnology company focused on restoring function in the innate immune system to fight disease. These innovative treatments are currently being developed for neurologic disease and certain forms of cancer.

  • KL Midori
  • Mahzi

    Our research and development efforts are focused exclusively on rare genetic neurodevelopmental disorders, a group of serious diseases with few or no treatment options. Our goal is to choose the best therapeutic approach for each individual disease and to advance that potential medicine as rapidly as possible.

  • MannKind

    At MannKind, we are dedicated to transforming chronic disease through innovative, patient-centric solutions designed to fit seamlessly into daily life. Our focus is on delivering therapies for people living with cardiometabolic and orphan lung diseases such as diabetes, pulmonary hypertension and fluid overload in heart and chronic kidney disease.

  • Mercury Bio

    Mercury Bio is an intracellular immunotherapeutic biotechnology company creating precision medicines designed to treat disease at its origin. We focus on developing therapies for diseases driven by intracellular pathology, with initial therapeutic priority on neurodegenerative conditions like Parkinson’s and Alzheimer’s diseases.

  • Mesoblast

    Mesoblast is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions.

  • Milestone Heights Consulting

    At Milestone Heights, clients get the best of both worlds: direct senior level partnership with Marnie, and access to a curated network of experts designed to meet the needs of each engagement.

  • Miltenyi

    Our mission is to advance scientific understanding and medicine by providing solutions for cell and gene therapy and biomedical research. We believe in biomedical science as the strongest driver to change the way we treat cancer, autoimmune diseases, and neurodegenerative disorders.

  • Moderna

    Our mission is to deliver the greatest possible impact to people through mRNA medicines.

  • Moffitt Cancer Center

    At Moffitt, ours is an unrelenting mission to save more lives. That's why we are accelerating the science with greater urgency than ever before.

  • Nionyx Bio

    Nionyx is developing next-generation Adeno-Associated Virus (AAV) gene therapies for genetic kidney diseases.

  • OneWeReach

    OneWe Reach is a premier non-profit organization dedicated to empowering and advancing professionals in the pharmaceutical and life sciences industry.

  • OS Therapies

    OS Therapies (OST) is a clinical-stage cancer immunotherapy company dedicated to developing a new way of activating the immune system to kill cancers like Breast Cancer, Colorectal Cancer and other solid tumors.

  • Ovid Therapeutics

    Ovid was founded with the hope and determination to meaningfully improve the lives of people and families affected by neurological diseases. We are developing a next generation of targeted small molecule therapies that seek to reduce seizures and deliver improved safety and tolerability.

  • Pharvaris

    Pharvaris (PHVS) is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs and improve standard of care in bradykinin-mediated angioedema.

  • Praxis Precision Medicines

    Praxis Precision Medicines is a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, translating insights from genetic epilepsies into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance.

  • Prilenia

    Prilenia is dedicated to developing new treatments for the urgent needs facing patients and families with Huntington’s disease, amyotrophic lateral sclerosis (ALS), and other neurodegenerative diseases.

  • Promontory Therapeutics

    We are developing novel small molecules with immunotherapeutic effects. Our lead agent, PT-112, has been shown in Phase 2 patients to generate adaptive and innate anti-cancer immune responses.

  • Rezolute

    We are developing and delivering novel therapies for rare diseases to significantly improve the quality of life for patients and their families.

  • Rocket Pharmaceuticals

    Seeking gene therapy cures that correct rare and devastating diseases at their root cause. Cures that represent freedom – freedom for patients and their loved ones to fully live in a world without the burden of genetic disease.

  • Saol Therapeutics

    Saol Therapeutics (pronounced "Sail") is focused on late-stage clinical development in CNS disorders such as pain and spasticity, and orphan diseases.

  • SciLucent, Inc.

    SciLucent helps biotech, pharmaceutical, medical device, and other life sciences companies advance development programs and navigate FDA requirements through experienced clinical, regulatory, scientific, quality, and operational support.

  • SSI Strategy

    We are your dedicated partner in turning groundbreaking ideas into tangible solutions that make a difference. Combining our therapeutic expertise with strategic problem-solving, we help you overcome obstacles and reach every milestone on your journey.

  • Stark Therapeutics

    Revolutionizing the Way the World Treats Chronic Diseases

  • Syneos

    Syneos Health is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.

  • Unicycive

    Unicycive was founded to identify overlooked opportunities and turn them into life-changing medicines for patients in need. With cutting-edge science, a best-in-class team, and a fearless approach to innovation, we deliver value when it’s needed most—because patients can’t afford to wait.

  • UTMB

    University of Texas Medical Branch - where purpose and passion come together in every patient interaction at UTMB. Here, caregivers learn what exceptional care means and carry it forward—healing patients in our communities and around the world.

  • Vera Tx

    We pursue truth in science to transform medicine in autoimmune diseases, starting with the kidney. We’re working towards a future where patients with autoimmune driven kidney diseases are free from needing dialysis or transplant.

Join